CollabRx Announces Receipt of NASDAQ Notice of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
CollabRx Announces Receipt of NASDAQ Notice of Noncompliance for Bid Price

SAN FRANCISCO, June 5, 2015 (GLOBE NEWSWIRE) -- CollabRx, Inc. (Nasdaq: CLRX ) (herein "CLRX" or "the Company"), announced today that it received a letter from The NASDAQ Stock Market LLC ("Nasdaq") stating that the bid price of the Company's common stock for the last 30 consecutive business days had closed below the minimum $1.00 per share required for continued listing under Listing Rule 5550(a)(2).

The Nasdaq notification letter does not result in the immediate delisting of the Company's common stock, and the stock will continue to trade uninterrupted on The Nasdaq Capital Market under the symbol "CLRX."

CollabRx has been provided a grace period of 180-calendar days, or until November 30, 2015, to regain compliance with the minimum bid price requirement. If at any time during the 180-day grace period, the minimum closing bid price per share of the Company's common stock closes at or above $1.00 for a minimum of ten consecutive business days (the Nasdaq Staff has the discretion to monitor the stock price for up to 20 trading days), CLRX will regain compliance and the matter will be closed. In the event the Company does not regain compliance within this grace period, it may be eligible to receive an additional 180-day grace period, provided that CLRX meets the continued listing requirement for market value of publicly held shares and all other initial listing standards for The Nasdaq Capital Market, with the exception of the minimum bid price requirement, and provides written notice of its intention to cure the minimum bid price deficiency during the second 180-day grace period by effecting a reverse stock split, if necessary. In the event the Company is not able to regain compliance by the end of the applicable grace period, the Company's securities would be subject to delisting unless the Company requested a hearing before the Nasdaq Listing Qualifications Panel.

CollabRx management intends to monitor the stock price and is considering available actions that could be taken to regain compliance if the stock price remains below the $1.00 per share requirement at the end of the applicable grace period.

On April 16, 2015 CollabRx and Medytox Solutions, Inc. (OTCQB:MMMS) ("Medytox") announced that they had entered into a definitive merger agreement. Since the signing, both parties have been working to complete a joint proxy statement/prospectus on Form S-4, which is expected to be filed with the SEC later this month. Closing of the merger is subject to, among other things, gaining stockholder approvals from both companies, receipt of regulatory approvals and other customary closing conditions. The combined entity will be required to meet the Nasdaq initial listing requirements. By so doing, the combined entity would also address the current bid price deficiency.

About CollabRx

CollabRx, Inc. ( CLRX ) is a recognized leader in cloud-based expert systems to inform healthcare decision-making. CollabRx uses information technology to aggregate and contextualize the world's knowledge on genomics-based medicine with specific insights from the nation's top cancer experts, starting with the area of greatest need: advanced cancers in patients who have effectively exhausted the standard of care. More information may be obtained at http://www.collabrx.com .

CollabRx Safe Harbor Statement

This press release includes forward-looking statements about CollabRx's anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and CollabRx's plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by CollabRx with the Securities and Exchange Commission. CollabRx undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.

Thomas R. Mika President & CEO CollabRx, Inc. 415-248-5350 Dian Griesel Int'l. Laura Radocaj- media 212- 825-3210 Cheryl Schneider- investors 212-825-3210

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LAFC Turns Empty Seats Into an AI Test Case for Sports

Updated Category News Views 81

Empty seats are a lousy kind of inventory A vacant stadium seat is perishable inventory with the clock screaming at it. LAFC and AccelerAI have aimed their first co-developed AI project at that unglamorous but important problem: getting more ticket holders through the gate without simply hacking prices down at the last minute. That is a far more sensible use of artificial...

Continue Reading
Paratus on the Move: Seagems JV Under the Microscope

Updated Category News Views 178

What's Cooking with Paratus Energy? Paratus Energy Services Ltd. (ticker: PLSV) just threw us a curveball, announcing a strategic review of its participation in the Seagems joint venture. Now, before you get too jazzed about ticker talk—hold your horses. No one's making any promises about transactions just yet. The decision's still hanging in the balance, even as they...

Continue Reading
Iberostar's Grand Move: Opening in Zanzibar

Updated Category News Views 135

The Resort That Takes Your Breath Away Here we have Iberostar, boldly wading into the azure waters of the Indian Ocean, planting its flag on the sandy beaches of Zanzibar. This isn’t just another notch on the resort’s belt—it’s their first time setting up shop in East Africa, a move ripe with promise and adventure both. A Suite So Sweet 358 suites, mind you. Each...

Continue Reading
Auria, LSAS Team Up: Japan Space Frontier Beckons

Updated Category News Views 105

Pioneering Ventures in Japan's Space Race Watch out, folks—Auria and LSAS Tec have something cooking. One's a titan in space technology, and the other's a maestro in mission analysis. They're joining forces to tango in Japan's booming space market. If you're into the street-smart equity dance, this partnership ain't just chatter over coffee; it's a leap toward new...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
AI Echo Study Sharpens a Difficult HFpEF Diagnosis

Updated Category News Views 88

A single echo clip may be doing more useful work than plenty of flashy healthcare AI demos. The November 2026 Journal of Cardiac Failure focus issue puts a hard number on that possibility: pairing an AI read of a routine echocardiogram clip with the H?FPEF clinical score identified 78% of patients with hemodynamically confirmed HFpEF, versus 48% with the score alone. That...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 95

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Elisity’s Texas Water Pilot Puts IonQ’s Deal in View

Updated Category News Views 189

Water-system security is not a place for chest-thumping Elisity’s role in Texas Project Watershed 250 lands on a problem that is painfully concrete: water and wastewater utilities have to keep pumps, treatment systems and plant operations running while trying to close cybersecurity gaps. That is a tougher job than selling another dashboard to a corporate IT department....

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 156

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading

Top 5 Most Recently Viewed Articles

Stocks Poised for Growth in Light of China's Rate Cuts

Updated Category News Views 81

Stocks Poised for Growth in Light of China's Rate Cuts As interest rates in China witness a significant reduction, investors' attention has naturally gravitated towards key Chinese stocks, which are experiencing renewed interest and rapid rallies. However, it may be wise to look beyond these familiar names and consider other companies that stand to benefit indirectly from...

Continue Reading
Vapotherm and Flight Medical Forge New Path for Ventilators

Updated Category News Views 264

Vapotherm and Flight Medical Forge New Path for Ventilators In a significant move for critical care, Vapotherm, Inc. has partnered with Flight Medical Innovations Ltd. to introduce the VentO2ux™ ventilator to hospitals throughout the United States. This collaboration marks a pivotal expansion for Vapotherm, known for its advanced respiratory support technologies, by...

Continue Reading
C1Risk Chosen to Enhance Government GRC Capabilities

Updated Category News Views 222

C1Risk Selected for Statewide Public Benefits System A major government organization has opted for C1Risk as its platform for Governance, Risk, and Compliance (GRC). This decision represents a crucial advancement in modernizing oversight within public benefits systems, highlighting the increasing necessity for efficient compliance automation for government entities....

Continue Reading
Exploring the Growth of the Self-Adhesive Tear Tapes Market

Updated Category News Views 151

Growth Potential of the Self-Adhesive Tear Tapes Market The self-adhesive tear tapes market is poised for substantial growth, projected to reach $281.9 million as demand for secure and convenient packaging continues to rise. This growth trajectory emphasizes not only the popularity of these tapes across various industries but also reflects ongoing advancements in...

Continue Reading
Shandong Radio and Television Station's Documentary Event Enriches Cultural Exchange

Updated Category News Views 154

Shandong Radio and Television Station's Documentary Event at a Prestigious University In an exciting collaboration, Shandong Radio and Television Station, along with its partner organizations, recently hosted a documentary promotion and screening event at a prominent university. This event provided an incredible opportunity for students and faculty to immerse themselves...

Continue Reading